CCE sells major solar project in Romania

Business Forum
CMS has advised CCE on the sale of Horia Solar Invest Two, a special purpose vehicle developing a 269.227 MW (AC)/ 293.260 MWp solar project spanning more than 349 hectares in Arad County (Horia 2), to Renalfa Solarpro Group.

CCE is an integrated developer and operator of Solar PV and Storage projects across Europe and Chile, with a pipeline of over 7.2 GW under development. Renalfa Solarpro Group is a player in the renewable energy sector, with a presence in CEE.

Varinia Radu, Head of Energy and Projects at CMS Romania, added: "This transaction shows that the trend in the M&A RES energy market is still strong, with consolidations of portfolios from some of the players; we are delighted to have been instrumental in bringing this deal to fruition, as Horia 2 is shaping to be one of the largest solar projects in the country. This transaction is a perfect example of investors' persistent confidence in the Romanian market."

The transaction is due to complete in Q1 2026 subject to fulfillment of the necessary conditions precedent, and the parties undertook to continue collaborating until the project reaches the commercial operation stage.

RECOMMENDED
Simtel completes Romanias largest solar park on degraded land
Energy

Simtel completes Romania's largest solar park on degraded land

Romanian engineering group Simtel Team has commissioned its photovoltaic park in Giurgiu, Romania's largest solar park built on degraded land. The facility has an installed capacity of 52 MWp and an estimated annual production of approximately 73 GWh.

Agroland Group secures €1 million for solar investment
Agriculture

Agroland Group secures €1 million for solar investment

Agroland Group, specialized in retail, agribusiness, food production, and animal nutrition, has secured nearly €1 million in grants through the Modernization Fund to develop four photovoltaic power plants with a total installed capacity of 1.62 MW.

RECOMMENDED FROM THE HOME PAGE
Industry

Life sciences M&A surges 81% as big pharma hunts for growth, says EY

Global life sciences M&A activity increased by 81% in 2025 to $240 billion, driven by Big Pharma's large-scale deals, despite fewer overall transactions. The surge reflects companies prioritising innovations ready for launch as they face widening growth gaps.

Finance

Electro-Alfa plans IPO on BVB

Electro-Alfa International, a Romanian electrical equipment manufacturer, has announced plans for an Initial Public Offering (IPO) on the Bucharest Stock Exchange (BVB).

READ MORE
Business Forum  |  19 January, 2026 at 12:06 PM
Business Forum  |  16 January, 2026 at 5:00 PM